Medicines and Poisons (Medicines) Regulation 2021
Table of Reprints
| Effective Date | Publication Date | Amendments Included | Notes |
|---|---|---|---|
| 27 September 2021 | 23 December 2021 |
provs comm, RA ss 7(1)(k), 26, 40 |
|
| 01 July 2022 | 2022 SL No. 402022 SL No. 77 | ||
| 01 October 2022 | 20 January 2023 | 2022 SL No. 129 | |
| 01 March 2023 | 01 March 2023 | 2023 SL No. 6 | |
| 02 June 2023 | 05 June 2023 | 2023 Act No. 14 | |
| 01 July 2023 | 04 July 2023 | 2023 SL No. 51 | |
| 30 October 2023 | 30 October 2023 | 2023 SL No. 152 | |
| 01 December 2023 | 05 December 2023 | 2023 SL No. 170 | |
| 01 February 2024 | 29 January 2024 | 2023 SL No. 170 | |
| 01 May 2024 | 02 May 2024 | 2024 SL No. 44 | |
| 01 July 2024 | 09 July 2024 | 2024 SL No. 442024 SL No. 102 | |
| 01 September 2024 | 04 September 2024 | 2024 SL No. 142 | |
| 01 October 2024 | 01 October 2024 | 2024 SL No. 230 | |
| 07 April 2025 | 04 April 2025 | 2025 SL No. 19 | |
| 01 July 2025 | 01 July 2025 | 2025 SL No. 60 | |
| 08 August 2025 | 08 August 2025 | 2025 SL No. 90 | |
| 01 December 2025 | 01 December 2025 | 2025 SL No. 148 |
List of Legislation
Medicines and Poisons (Medicines) Regulation 2021 SL No. 140
notfd 17 September 2021
ss 1–2 comm on date of notification
chs 1 (other than ss 1–2), 2–11, schs 1–23 comm 27 September 2021 (see s 2)
exp 1 September 2032 (see SIA s 54)
Amending legislation
Health Legislation (Fee Unit Conversion) Amendment Regulation 2022 SL No. 40
notfd 29 April 2022
pt 4 comm 1 July 2022 (see s 2)
Medicines and Poisons (Medicines) Amendment Regulation 2022 SL No. 77
notfd 24 June 2022
ss 3–12 comm 1 July 2022 (see s 2)
Medicines and Poisons (Medicines) Amendment Regulation (No. 2) 2022 SL No. 129
notfd 23 September 2022
ss 3–4 comm 1 October 2022 (see s 2)
Medicines and Poisons (Medicines) Amendment Regulation 2023 SL No. 6
notfd 24 February 2023
ss 3–8 comm 1 March 2023 (see s 2)
Corrective Services (Emerging Technologies and Security) and Other Legislation Amendment Act 2023 No. 14
date of assent 02 June 2023
sch 1 comm on date of assent
Medicines and Poisons (Medicines) Amendment Regulation (No. 2) 2023 SL No. 51
notfd 16 June 2023
ss 3–10 comm 1 July 2023 (see s 2)
Medicines and Poisons (Medicines) Amendment Regulation (No. 3) 2023 SL No. 152
notfd 27 October 2023
ss 3–5 comm 30 October 2023 (see s 2)
Medicines and Poisons (Medicines) Amendment Regulation (No. 4) 2023 SL No. 170
notfd 01 December 2023
pt 2 comm 1 December 2023 (see s 2 (1))
pt 3 comm 1 February 2024 (see s 2 (2))
Medicines and Poisons (Medicines) Amendment Regulation 2024 SL No. 44
notfd 26 April 2024
pt 2 comm 1 May 2024 (see s 2 (1))
pt 3 comm 1 July 2024 (see s 2 (2))
Medicines and Poisons (Medicines) Amendment Regulation (No. 2) 2024 SL No. 102
notfd 28 June 2024
ss 3–9 comm 1 July 2024 (see s 2)
Health Legislation (Ratios and Other Matters) Amendment Regulation 2024 SL No. 142
notfd 09 August 2024
pt 3 comm 1 September 2024 (see s 2)
Medicines and Poisons (Medicines) Amendment Regulation (No. 3) 2024 SL No. 230
notfd 27 September 2024
ss 3–8 comm 1 October 2024 (see s 2)
Medicines and Poisons (Medicines) Amendment Regulation 2025 SL No. 19
notfd 04 April 2025
ss 3–10 comm 7 April 2025 (see s 2)
Medicines and Poisons (Medicines) Amendment Regulation (No. 2) 2025 SL No. 60
notfd 27 June 2025
ss 3–16 comm 1 July 2025 (see s 2)
Medicines and Poisons (Medicines) Amendment Regulation (No. 3) 2025 SL No. 90
notfd 08 August 2025
comm on date of notification
Medicines and Poisons (Medicines) Amendment Regulation (No. 4) 2025 SL No. 148
notfd 28 November 2025
ss 3–41 comm 1 December 2025 (see s 2)
History notes
s 6 amd 2023 SL No. 170 s 4
s 6A ins 2023 SL No. 51 s 4
s 6B ins 2024 SL No. 102 s 4
s 6C ins 2025 SL No. 19 s 4
s 73 amd 2023 SL No. 170 s 5
s 84 amd 2022 SL No. 77 s 4
s 86 amd 2025 SL No. 148 s 4
s 87 amd 2022 SL No. 77 s 5; 2025 SL No. 148 s 5
s 104 amd 2023 SL No. 6 s 4
s 117 amd 2023 SL No. 170 s 14
sub 2025 SL No. 60 s 5
s 117A ins 2025 SL No. 60 s 5
s 117B ins 2025 SL No. 60 s 5
s 153 amd 2025 SL No. 60 s 7
s 155 def pre-packed ins 2025 SL No. 60 s 8(2)
s 156 amd 2025 SL No. 60 s 9
s 157 amd 2025 SL No. 60 s 10
s 158 sub 2025 SL No. 60 s 11
s 159 amd 2022 SL No. 77 s 6; 2023 SL No. 170 s 16
sub 2025 SL No. 60 s 11
s 160 amd 2025 SL No. 60 s 12
s 161 amd 2023 SL No. 51 s 5; 2025 SL No. 148 s 6
s 178A ins 2024 SL No. 44 s 5
s 195 def shared clinic amd 2022 SL No. 77 s 7
s 199 amd 2024 SL No. 230 s 4
s 221 amd 2023 SL No. 170 s 6
s 226 amd 2024 SL No. 230 s 5
s 234 amd 2025 SL No. 148 s 7
s 236 amd 2024 SL No. 102 s 5
s 237 amd 2023 SL No. 170 s 7
sch 1 amd 2022 SL No. 77 s 8; 2022 SL No. 129 s 4; 2023 SL No. 6 s 5; 2023 SL No. 51 s 6; 2023 SL No. 152 s 4; 2023 SL No. 170 ss 8, 17; 2024 SL No. 44 ss 4, 6; 2024 SL No. 102 s 6; 2024 SL No. 142 s 8; 2025 SL No. 19 s 5; 2025 SL No. 60 s 13; 2025 SL No. 148 s 8
sch 2 amd 2022 SL No. 77 s 9; 2023 SL No. 51 s 7; 2023 SL No. 170 s 9; 2024 SL No. 230 s 6; 2025 SL No. 90 s 3; 2025 SL No. 148 s 9
sch 3 pt 1 hdg amd 2023 SL No. 6 s 6 (1)
sch 3 s 1 def relevant health service om 2023 SL No. 6 s 6 (2)
sch 3 s 2 sub 2023 SL No. 6 s 6 (3)
sch 3 s 3 amd 2023 SL No. 6 s 6 (4)
sch 3 pt 1A hdg ins 2023 SL No. 6 s 6 (5)
sch 3 pt 1A div 1 hdg ins 2023 SL No. 6 s 6 (5)
sch 3 s 3A ins 2023 SL No. 6 s 6 (5)
sch 3 pt 1A div 2 hdg ins 2023 SL No. 6 s 6 (5)
sch 3 s 3B ins 2023 SL No. 6 s 6 (5)
sch 3 s 3C ins 2023 SL No. 6 s 6 (5)
sch 4 pt 5 div 1 hdg ins 2025 SL No. 60 s 14
s 14 ins 2025 SL No. 60 s 14
sch 4 pt 5 div 2 hdg ins 2025 SL No. 60 s 14
s 15 ins 2025 SL No. 60 s 14
s 16 ins 2025 SL No. 60 s 14
sch 6 s 5 def continuing institutional treatment amd 2025 SL No. 90 s 4(3)
sch 6 s 5 def continuing opioid dependence treatment ins 2025 SL No. 90 s 4(2)
sch 6 s 5 amd 2025 SL No. 90 s 4(1)
sch 6 s 7 amd 2025 SL No. 90 s 4(4)
sch 6 s 11 sub 2025 SL No. 148 s 16
sch 6 s 20 amd 2023 SL No. 51 s 8 (1)
sch 6 s 22 amd 2022 SL No. 77 s 10 (1)–(2); 2023 SL No. 51 s 8 (2); 2023 SL No. 170 s 10(1); 2025 SL No. 148 s 18
sch 6 s 26 amd 2023 SL No. 51 s 8 (3)
sch 6 pt 2 div 5A hdg prev sch 6 pt 2 div 5A hdg ins 2022 SL No. 77 s 10 (3)
om 2023 SL No. 170 s 10 (2)
pres sch 6 pt 2 div 5A hdg ins 2025 SL No. 148 s 20
sch 6 s 26A prev sch 6 s 26A ins 2022 SL No. 77 s 10 (3)
om 2023 SL No. 170 s 10(2)
pres sch 6 s 26A ins 2025 SL No. 148 s 20
sch 6 s 26B prev sch 6 s 26B ins 2022 SL No. 77 s 10 (3)
om 2023 SL No. 170 s 10 (2)
pres sch 6 s 26B ins 2025 SL No. 148 s 20
sch 6 s 30 amd 2023 SL No. 51 s 8 (4)
sch 6 s 32 amd 2022 SL No. 77 s 10 (1); 2025 SL No. 148 s 21
sch 6 s 36 amd 2022 SL No. 77 s 10 (4); 2023 SL No. 170 s 10(3); 2025 SL No. 148 s 23
sch 6 s 45 def relevant child condition sub 2025 SL No. 148 s 26(1)
sch 6 s 45 def young adult ADHD ins 2025 SL No. 148 s 26(1)
sch 6 s 45 sub 2025 SL No. 148 s 26(1)
sch 6 s 47 amd 2022 SL No. 77 s 10 (5); 2023 SL No. 170 s 10(4)
sub 2025 SL No. 148 s 26(2)
sch 6 s 48 def adult ADHD ins 2025 SL No. 148 s 27(2)
sch 6 s 48 def maximum dosage om 2025 SL No. 148 s 27(1)
sch 6 s 48 def relevant adult condition om 2025 SL No. 148 s 27(1)
sch 6 s 48 def relevant child condition sub 2025 SL No. 148 s 27(1)–(2)
sch 6 s 50 amd 2023 SL No. 51 s 8 (5)–(6)
sub 2025 SL No. 148 s 27(3)
sch 6 s 52 sub 2022 SL No. 77 s 10 (6)
amd 2023 SL No. 51 s 8 (7)
sch 6 s 54 amd 2023 SL No. 51 s 8 (8); 2025 SL No. 148 s 28
sch 6 s 58 amd 2022 SL No. 77 s 10 (1); 2023 SL No. 51 s 8 (9); 2025 SL No. 148 s 29
sch 7 s 1 def continuing hydroxchloroquine treatment om 2025 SL No. 148 30(1)
sch 7 s 1 def continuing institutional treatment amd 2025 SL No. 90 s 5(2)
sch 7 s 1 def continuing opioid dependence treatment ins 2025 SL No. 90 s 5(1)
sch 7 s 3 amd 2024 SL No. 102 s 7; 2025 SL No. 90 s 5(3)–(4); 2025 SL No. 148 s 30(2)
sch 7 s 9 def custodial patient ins 2025 SL No. 19 s 6(2)
sch 7 s 9 def prison patient om 2025 SL No. 19 s 6(1)
sch 7 s 16 sub 2025 SL No. 19 s 6(3)
sch 7 s 17 sub 2025 SL No. 19 s 6(3)
amd 2025 SL No. 148 s 31
sch 7 s 19 amd 2023 SL No. 170 s 11
sch 8 s 1 def optometry guidelines amd 2022 SL No. 77 s 11 (1)
sch 8 s 3 amd 2022 SL No. 77 s 11 (2)
sch 9 s 2 amd 2024 SL No. 102 s 8; 2024 SL No. 230 s 7
sch 9 pt 1 div 1A hdg ins 2023 SL No. 152 s 5
sch 9 s 2A ins 2023 SL No. 152 s 5
sch 9 s 2B ins 2023 SL No. 152 s 5
sch 9 s 4A def community pharmacy chronic conditions management pilot ins 2025 SL No. 60 s 15(1)
sch 9 s 4A def community pharmacy scope of practice pilot om 2025 SL No. 60 s 15(1)
sch 9 s 4A def participating pharmacist amd 2025 SL No. 60 s 15(2)
sch 9 s 4A def participating pharmacy amd 2025 SL No. 60 s 15(2)
amd 2025 SL No. 60 s 15(3)–(4)
sch 9 s 6 amd 2025 SL No. 60 s 15(5)
sch 9 s 8 amd 2025 SL No. 60 s 15(6)–(7)
sch 12 s 2 sub 2023 SL No. 170 s 12
sch 12 s 9 amd 2025 SL No. 148 s 37(1)
sch 12 s 10 amd 2025 SL No. 148 s 37(2)
sch 12 s 12 amd 2023 SL No. 51 s 9; 2025 SL No. 148 s 38(1)
sch 12 s 13 amd 2025 SL No. 148 s 38(2)
sch 13 pt 3 hdg amd 2025 SL No. 148 s 40(1)
sch 13 s 16 amd 2025 SL No. 148 s 40(2)
sch 13 s 30 def registered vaccine service provider om 2025 SL No. 19 s 8(1)
s 30 om 2025 SL No. 19 s 8(1)
sch 13 s 31 amd 2025 SL No. 19 s 8(2)
sch 13 s 32 amd 2025 SL No. 19 s 8(3)–(4)
sch 14 s 4 amd 2025 SL No. 90 s 7(1)
sch 14 s 6 amd 2025 SL No. 90 s 7(2)
sch 18 amd 2024 SL No. 44 s 7
sch 19 amd 2022 SL No. 40 s 8
sch 20 amd 2023 SL No. 6 s 7
sch 22 def Aboriginal or Torres Strait Islander health service amd 2023 SL No. 6 s 8 (2)
sch 22 def ADHD ins 2025 SL No. 148 s 41(2)
sch 22 def adrenaline (epinephrine) autoinjector amd 2022 SL No. 77 s 12 (2)
om 2025 SL No. 148 s 41(1)
sch 22 def adrenaline (epinephrine) device ins 2025 SL No. 148 s 41(2)
sch 22 def anaphylaxis training amd 2025 SL No. 148 s 41(3)
sch 22 def Australian Register of Therapeutic Goods ins 2022 SL No. 77 s 12 (1)
sch 22 def community pharmacy sub 2024 SL No. 230 s 8
sch 22 def compound amd 2024 SL No. 102 s 9(2)
sch 22 def corrective services facility ins 2024 SL No. 44 s 8(1)
sch 22 def custodial facility ins 2024 SL No. 44 s 8(1)
sch 22 def detention centre amd 2023 Act No. 14 s 52 sch 1
sch 22 def enrolled nurse amd 2025 SL No. 60 s 16(2)
sch 22 def immunisation medicine ins 2025 SL No. 19 s 10
sch 22 def manufacturer’s pack amd 2023 SL No. 170 s 13(3)
sch 22 def maximum daily dose ins 2025 SL No. 148 s 41(2)
sch 22 def MDMA ins 2023 SL No. 51 s 10
sch 22 def patient amd 2024 SL No. 44 s 8(2)
sch 22 def pre-packed ins 2025 SL No. 60 s 16(1)
sch 22 def psychostimulant medicine ins 2025 SL No. 148 s 41(2)
sch 22 def registered immunisation service provider ins 2025 SL No. 19 s 10
sch 22 def registered medicine amd 2022 SL No. 77 s 12 (3)
om 2024 SL No. 102 s 9(1)
sch 22 def relevant health service ins 2023 SL No. 6 s 8 (1)
sch 22 def restricted ivermectin ins 2022 SL No. 77 s 12 (1)
om 2023 SL No. 170 s 13(1)
sch 22 def specialist medical practitioner ins 2025 SL No. 148 s 41(2)
sch 22 def therapeutic nicotine ins 2024 SL No. 230 s 8(2)
sch 22 def therapeutic vaping good ins 2024 SL No. 230 s 8(2)
sch 22 amd 2023 SL No. 170 s 13(2)
Medicines and Poisons (Medicines) Regulation 2021
| Notification: 17 September 2021 |  2021 SL No. 140
 2021 SL No. 140
Explanatory Note
Explanatory
Note
Human Rights Certificate
Human Rights
Certificate
|
| Tabled: 12 October 2021 |